Source: The Korea Bizwire

Olon: Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France

MILAN, April 28, 2025 (Korea Bizwire) - Olon Group, a leading global pharmaceutical CDMO, announces the appointment of Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP CDMO of Olon Biotech, the division dedicated to CDMO services for biologics. These appointments reinforce Olon's strategy to expand its capabilities in Antibody-Drug Conjugates [...]The post Olon Group Strengthens Its Leadership in Bioproduction with Two Strategic Appointments in France appeared first on Be Korea-savvy.

Read full article »
Est. Annual Revenue
$500M-1.0B
Est. Employees
1.0-5.0K
Paolo Tubertini's photo - CEO of Olon

CEO

Paolo Tubertini

CEO Approval Rating

90/100

Read more